Intravenous iron sucrose in postnatal iron deficiency anaemia: A safe option

Abstract

Introduction: Iron deficiency anaemia is the most common type of reversible anemia encountered during postpartum period and may lead to long-standing iron deficiency. If treated, it facilitates a healthy future for mother and children. Aims and Objectives: To know safety of intravenous iron sucrose in treatment of postpartum iron deficiency anaemia. Materials and Methods: 91 postnatal women with iron deficiency anaemia with haemoglobin between 7-10g/dl were included prospectively at IGGMCH Nagpur. These women were given 200 mg of elemental iron infused over 30 minutes every alternate day until the required dosage is infused. The blood samples of all the patients were collected and analyzed for Hb and other RBC indices before and after therapy. Result: Majority of the patients were multi-para (63.76%) belonging to lower socio-economic groups. All blood parameters were increased significantly when compared from baseline values. Mean raise in Hb, hematocrit, MCV, MCH, MCHC and serum ferritin are 1.3, 2.3, 3.4fL, 2.3pg, 3.5 gm/dl and 53.71mcg/l respectively after 30 days of treatment. Conclusion: Intravenous iron sucrose was very well tolerated and safe for treating postnatal iron deficiency anaemia.